Product Details:
Number of Reactions(Preps)/Kit 30T
Brand CTK BioTech
ICMR Approved Yes
Result Time (Rapid Kits) 20min
CAT No : AR5001C
Details :
Utilizes Recombinant Orientia tsutsugamushi antigens.
Qualitative detection and differentiation of antibodies(IgG and IgM) against Orientia tsutsugamushi (Scrub typhus)
Compatible with Whole blood, Serum and Plasma.
Sensitivity: For IgG 95.4% and IgM 96.1%, Specificity: For IgG 96.8% and IgM 97.6%.
Results in 20 minutes.
Each kit contains:
Individually sealed foil pouches containing:
One cassette device
One desiccant
Detection buffer (tris-based buffered solution with preservatives)
Instructions for Use
For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing. 1.Easy to collect samples simple operation without professional equipment. 2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy. 4.Suitable for large-scale rapid screening. Shelf life: 24 Months Test Result time: 10 Mins Packing: 25 Pieces per Box
Supplier: Rapid detection kit, ribonucleic acid detection reagent, medical syringes, medical mask, medical ventilator, medical glove, medical isolation gown, surgical gown level 3+4, protective gown (overall ), oximeter, other medical products
Specification Strength/ Size Packing Size Packed In Filariasis Kit Includes One test Strip, Desiccant and Dropper 50 Strip Test Per Pack 50 Box Pack
The Typhoid IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of anti-Salmonella typhi (S. typhi)G and IgM in human serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with S. typhi. Any reactive specimen with the Typhoid IgG/IgM 2.0 Rapid Test must be confirmed with alternative testing method(s).
The Cytomegalovirus Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of Cytomegalovirus (CMV) in human serum/plasma samples. Cytomegalovirus is a herpes virus and a leading biological factor causing congenital abnormalities and complications among those who receive massive blood transfusions and immunosuppressive therapy. About half of the number of pregnant women who contract a primary infection, spread the disease to their fetus. When acquired in-utero, the infection may cause mental retardation, blindness, and/or deafness. Serological tests for detecting the presence of antibody to CMV can provide valuable information regarding the history of previous infection, diagnosis or active or recent infection, as well as in screening blood for transfusions in newborns and immuno-compromised recipients. The Cytomegalovirus Rapid Test Device (Serum/Plasma) has been designed to detect CMV through visual interpretation of color development in the internal strip. The membrane was immobilized with antigens of CMV on the test region. During the test, the specimen is allowed to react with colored recombinant mouse anti-human IgM latex conjugates, which were precoated on the sample pad of the test. The mixture then moves on the membrane by a capillary action, and interact with reagents on the membrane. If there were enough CMV antibodies in specimens, a colored band will from at the test region of the membrane. Presence of this colored band indicates a positive result, while its absence indicates a negative result. Appearance of a colored band at the control region serves as a procedural control. This indicates that proper volume of specimen has been added and membrane wicking has occurred.